Clinical Trial Update: A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial studying universal CD19-targeted UCAR-NK cells combined with hematopoietic stem cell transplantation for B cell hematologic malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoblastic Leukemia Lymphoma

Drugs mentioned

• UCAR-NK cells (universal CD19-targeted) (CD19-targeted UCAR-NK cells)

Snippet

Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN